Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-27
DOI
10.1038/s41467-017-02283-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors
- (2018) Adva Krivitsky et al. Nanomedicine-Nanotechnology Biology and Medicine
- Systemic delivery of siRNA by aminated poly( α )glutamate for the treatment of solid tumors
- (2017) Dina Polyak et al. JOURNAL OF CONTROLLED RELEASE
- Recent progress in development of siRNA delivery vehicles for cancer therapy
- (2016) Hyun Jin Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- Structure–Function Correlation of Aminated Poly(α)glutamate as siRNA Nanocarriers
- (2016) Adva Krivitsky et al. BIOMACROMOLECULES
- State of the art biological therapies in pancreatic cancer
- (2016) Mariacristina Di Marco World Journal of Gastrointestinal Oncology
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
- (2015) E Hessmann et al. ONCOGENE
- Small RNA combination therapy for lung cancer
- (2014) W. Xue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer
- (2014) Julian Swierczynski WORLD JOURNAL OF GASTROENTEROLOGY
- Paclitaxel Poliglumex, Temozolomide, and Radiation for Newly Diagnosed High-grade Glioma
- (2013) Suriya Jeyapalan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
- (2013) María P. Torres et al. PLoS One
- PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
- (2013) J. Tan et al. Cancer Discovery
- Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
- (2013) M. Nishimura et al. Cancer Discovery
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer
- (2012) B. Song et al. MOLECULAR CANCER THERAPEUTICS
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
- (2011) Kenoki Ohuchida et al. ANNALS OF SURGICAL ONCOLOGY
- AGR2 Is a Novel Surface Antigen That Promotes the Dissemination of Pancreatic Cancer Cells through Regulation of Cathepsins B and D
- (2011) L. Dumartin et al. CANCER RESEARCH
- MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- Paclitaxel poliglumex for ovarian cancer
- (2011) Vijaya L Galic et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
- (2011) D. Pramanik et al. MOLECULAR CANCER THERAPEUTICS
- In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging
- (2011) S. Eser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- A Fine-Needle Aspirate-Based Vulnerability Assay Identifies Polo-Like Kinase 1 as a Mediator of Gemcitabine Resistance in Pancreatic Cancer
- (2010) A. Jimeno et al. MOLECULAR CANCER THERAPEUTICS
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- MicroRNA-Based Therapeutics for Cancer
- (2009) Vivien Wang et al. BIODRUGS
- p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
- (2009) N R Christoffersen et al. CELL DEATH AND DIFFERENTIATION
- Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2009) Corey J. Langer et al. Journal of Thoracic Oncology
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics
- (2009) Ehud Segal et al. PLoS One
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- Overcoming the Innate Immune Response to Small Interfering RNA
- (2008) Adam Judge et al. HUMAN GENE THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now